Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
Diabetes affects the way the body uses blood sugar and can increase the risk of nerve damage
MIC shots carry additional considerations quality varies between compounding pharmacies, they are not FDA-regulated for weight loss, and those with liver or kidney conditions should consult their physician first
Description Overview BPC157 is a synthetic pentadecapeptide (15 amino acids) that comes from a fragment of a larger endogenous gastric protein complex commonly referred to as Body Protection Compound (BPC)
US$ 24.83
US$ 28.47
US$ 20.94
US$ 27.96
